补体靶向治疗的全球市场规模：按适应症（阵发性夜间溶血性尿毒症综合征、非典型溶血性尿毒症综合征）、按分销渠道、按地区2022-2028

补体靶向治疗的全球市场规模是慢性病的增加、补体靶向治疗临床研究的增加、近期的合作研究活动以及免疫系统疾病的流行。受到新兴国家医疗基础设施的增加和发展的推动。

另一方面，缺乏对补体不足的认识和高昂的治疗成本预计将阻碍预测期内市场的增长。

本报告调查了全球补体靶向治疗市场，并提供了全面的信息，包括市场概况、市场分析、适应症/分销渠道/区域分析和竞争格局。

目录

第 1 章执行摘要

第二章全球补体靶向治疗市场的定义和范围

第三章全球补体靶向治疗市场动态

• 补体靶向治疗药物市场影响分析（2020-2028）

第四章全球补体靶向治疗市场行业分析

• 波特五力模型
• PEST 分析
• 投资采用模式
• 分析师建议和结论
• 主要投资机会
• 关键成功策略

第 5 章风险评估：COVID-19 的影响

• 评估 COVID-19 对行业的整体影响
• COVID-19 前后的市场情景

第6章全球补体靶向治疗市场：按适应症

• 市场快照
• 通过适应症-潜力分析补充全球靶向治疗市场表现
• 全球补体靶向治疗药物市场按适应症的估计和预测（2018-2028）
• 补充靶向治疗市场，细分分析
  • 阵发性睡眠性血红蛋白尿
  • 非典型溶血性尿毒症综合征（Ahus）

第7章全球补体靶向治疗市场：按分销渠道

• 市场快照
• 分销渠道潜力分析的全球补充靶向治疗市场表现
• 按分销渠道划分的全球补体靶向治疗药物市场估计和预测（2018-2028）
• 补充靶向治疗市场，细分分析
  • 医院药房
  • 零售药店
  • 网上药店

第 8 章全球补体靶向治疗市场：按地区划分

• 区域市场概况
• 北美
  • 美国
  • 加拿大
• 欧洲快照
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 意大利
  • 其他欧洲
• 亚太地区概况
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 其他亚太地区
• 拉丁美洲快照
  • 巴西
  • 墨西哥
• 其他领域

第9章衝突信息

• 主要市场策略
• 公司简介
  • Creative Biolabs
  • Complement UK
  • Novartis Ag
  • Alexion Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Allergan Plc.
  • Abbvie
  • Sino Biological Inc.
  • Cascade Biotechnology Inc.

第10章 调查流程

Global Complement-targeted Therapeutics Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Complement-targeted Therapeutics can be defined as therapeutics that modulate the complement system. The complement system, also called as complement cascade, is a part of the immune system that enhances the ability of antibodies and phagocytic cells to clear microbes and damaged cells from an organism, and promote inflammation, as well as attack the pathogen's cell membrane. However, Activation of the complement system results in the pathogenesis of some diseases such as cancer, rheumatic diseases, Alzheimer's disease, autoimmune diseases, age-related macular degeneration, and schizophrenia among others. The increasing incidences of chronic diseases and growing number of clinical research in complement-targeted therapeutics as well as recent collaboration activities are factors that are accelerating the global market demand. For instance, according to World Health Organization - as of 2021, globally around 41 million people lost their lives due to Noncommunicable diseases (NCDs). NCDs are accounted for around 71% of all global deaths. IN NCDs Cardiovascular diseases account for largest number of deaths, or 17.9 million deaths, followed by cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million). Furthermore, in June 2021, Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Beam Therapeutics Inc. entered in a five-year research collaboration. Under this collaboration both the companies would utilize Beam's proprietary base editing technology to discover new treatments for complement-driven diseases. The companies would work together on six research programs focused on C3 and other complement targets in the eye, liver, and brain. Also, growing prevalence of immune system diseases and rising healthcare infrastructure in emerging economies are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, lack of awareness towards complements deficiency and high treatment cost impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Complement-targeted Therapeutics market study include: Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to growing number of clinical trials and presence of leading market players in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising healthcare infrastructure and increasing incidences of Noncommunicable diseases in the region, would create lucrative growth prospects for the Complement-targeted Therapeutics market across the Asia Pacific region.

Major market players included in this report are:

• Creative Biolabs
• Complement UK
• Novartis Ag
• Alexion Pharmaceuticals, Inc.
• Merck & Co., Inc.
• Pfizer Inc.
• Allergan Plc.
• Abbvie
• Sino Biological Inc.
• Cascade Biotechnology Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Indication

• Paroxysmal Nocturnal Haemoglobinuria
• Atypical Haemolytic Uraemic Syndrome (Ahus)

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
  • U.S.
  • Canada

• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE

• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC

• Latin America
  • Brazil
  • Mexico

• Rest of the World

Furthermore, years considered for the study are as follows:

• Historical year - 2018, 2019, 2020
• Base year - 2021
• Forecast period - 2022 to 2028

Target Audience of the Global Complement-targeted Therapeutics Market in Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
  • 1.2.1. Global Complement-targeted Therapeutics Market, by Region, 2020-2028 (USD Million)
  • 1.2.2. Global Complement-targeted Therapeutics Market, by Indication, 2020-2028 (USD Million)
  • 1.2.3. Global Complement-targeted Therapeutics Market, by Distribution Channel, 2020-2028 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Complement-targeted Therapeutics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Complement-targeted Therapeutics Market Dynamics

• 3.1. Complement-targeted Therapeutics Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidences of chronic diseases.
    • 3.1.1.2. Growing number of clinical research in complement-targeted therapeutics.
    • 3.1.1.3. Recent collaboration activities.
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of awareness towards complement deficiency.
    • 3.1.2.2. High treatment cost.
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing prevalence of immune system diseases
    • 3.1.3.2. Rising healthcare infrastructure in emerging economies.

Chapter 4. Global Complement-targeted Therapeutics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Complement-targeted Therapeutics Market, by Indication

• 6.1. Market Snapshot
• 6.2. Global Complement-targeted Therapeutics Market by Indication, Performance - Potential Analysis
• 6.3. Global Complement-targeted Therapeutics Market Estimates & Forecasts by Indication 2018-2028 (USD Million)
• 6.4. Complement-targeted Therapeutics Market, Sub Segment Analysis
  • 6.4.1. Paroxysmal Nocturnal Haemoglobinuria
  • 6.4.2. Atypical Haemolytic Uraemic Syndrome (Ahus)

Chapter 7. Global Complement-targeted Therapeutics Market, by Distribution Channel

• 7.1. Market Snapshot
• 7.2. Global Complement-targeted Therapeutics Market by Distribution Channel, Performance - Potential Analysis
• 7.3. Global Complement-targeted Therapeutics Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Million)
• 7.4. Complement-targeted Therapeutics Market, Sub Segment Analysis
  • 7.4.1. Hospital Pharmacies
  • 7.4.2. Retail Pharmacies
  • 7.4.3. Online Pharmacies

Chapter 8. Global Complement-targeted Therapeutics Market, Regional Analysis

• 8.1. Complement-targeted Therapeutics Market, Regional Market Snapshot
• 8.2. North America Complement-targeted Therapeutics Market
  • 8.2.1. U.S. Complement-targeted Therapeutics Market
    • 8.2.1.1. Indication estimates & forecasts, 2018-2028
    • 8.2.1.2. Distribution Channel estimates & forecasts, 2018-2028
  • 8.2.2. Canada Complement-targeted Therapeutics Market
• 8.3. Europe Complement-targeted Therapeutics Market Snapshot
  • 8.3.1. U.K. Complement-targeted Therapeutics Market
  • 8.3.2. Germany Complement-targeted Therapeutics Market
  • 8.3.3. France Complement-targeted Therapeutics Market
  • 8.3.4. Spain Complement-targeted Therapeutics Market
  • 8.3.5. Italy Complement-targeted Therapeutics Market
  • 8.3.6. Rest of Europe Complement-targeted Therapeutics Market
• 8.4. Asia-Pacific Complement-targeted Therapeutics Market Snapshot
  • 8.4.1. China Complement-targeted Therapeutics Market
  • 8.4.2. India Complement-targeted Therapeutics Market
  • 8.4.3. Japan Complement-targeted Therapeutics Market
  • 8.4.4. Australia Complement-targeted Therapeutics Market
  • 8.4.5. South Korea Complement-targeted Therapeutics Market
  • 8.4.6. Rest of Asia Pacific Complement-targeted Therapeutics Market
• 8.5. Latin America Complement-targeted Therapeutics Market Snapshot
  • 8.5.1. Brazil Complement-targeted Therapeutics Market
  • 8.5.2. Mexico Complement-targeted Therapeutics Market
• 8.6. Rest of The World Complement-targeted Therapeutics Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Creative Biolabs
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Complement UK
  • 9.2.3. Novartis Ag
  • 9.2.4. Alexion Pharmaceuticals, Inc.
  • 9.2.5. Merck & Co., Inc.
  • 9.2.6. Pfizer Inc.
  • 9.2.7. Allergan Plc.
  • 9.2.8. Abbvie
  • 9.2.9. Sino Biological Inc.
  • 9.2.10. Cascade Biotechnology Inc.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Complement-targeted Therapeutics Market, report scope
• TABLE 2. Global Complement-targeted Therapeutics Market estimates & forecasts by Region 2018-2028 (USD Million)
• TABLE 3. Global Complement-targeted Therapeutics Market estimates & forecasts by Indication 2018-2028 (USD Million)
• TABLE 4. Global Complement-targeted Therapeutics Market estimates & forecasts by Distribution Channel 2018-2028 (USD Million)
• TABLE 5. Global Complement-targeted Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 6. Global Complement-targeted Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 7. Global Complement-targeted Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 8. Global Complement-targeted Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 9. Global Complement-targeted Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 10. Global Complement-targeted Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 11. Global Complement-targeted Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 12. Global Complement-targeted Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 13. Global Complement-targeted Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 14. Global Complement-targeted Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 15. U.S. Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 16. U.S. Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 17. U.S. Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 18. Canada Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 19. Canada Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 20. Canada Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 21. UK Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 22. UK Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 23. UK Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 24. Germany Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 25. Germany Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 26. Germany Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 27. RoE Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 28. RoE Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 29. RoE Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 30. China Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 31. China Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 32. China Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 33. India Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 34. India Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 35. India Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 36. Japan Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 37. Japan Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 38. Japan Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 39. RoAPAC Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 40. RoAPAC Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 41. RoAPAC Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 42. Brazil Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 43. Brazil Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 44. Brazil Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 45. Mexico Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 46. Mexico Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 47. Mexico Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 48. RoLA Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 49. RoLA Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 50. RoLA Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 51. Row Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 52. Row Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 53. Row Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 54. List of secondary sources, used in the study of global Complement-targeted Therapeutics Market
• TABLE 55. List of primary sources, used in the study of global Complement-targeted Therapeutics Market
• TABLE 56. Years considered for the study
• TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global Complement-targeted Therapeutics Market, research methodology
• FIG 2. Global Complement-targeted Therapeutics Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Complement-targeted Therapeutics Market, key trends 2021
• FIG 5. Global Complement-targeted Therapeutics Market, growth prospects 2022-2028
• FIG 6. Global Complement-targeted Therapeutics Market, porters 5 force model
• FIG 7. Global Complement-targeted Therapeutics Market, pest analysis
• FIG 8. Global Complement-targeted Therapeutics Market, value chain analysis
• FIG 9. Global Complement-targeted Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 10. Global Complement-targeted Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 11. Global Complement-targeted Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 12. Global Complement-targeted Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 13. Global Complement-targeted Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 14. Global Complement-targeted Therapeutics Market, regional snapshot 2018 & 2028
• FIG 15. North America Complement-targeted Therapeutics Market 2018 & 2028 (USD Million)
• FIG 16. Europe Complement-targeted Therapeutics Market 2018 & 2028 (USD Million)
• FIG 17. Asia pacific Market 2018 & 2028 (USD Million)
• FIG 18. Latin America Complement-targeted Therapeutics Market 2018 & 2028 (USD Million)
• FIG 19. Global Complement-targeted Therapeutics Market, company Market share analysis (2021)